首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   19153篇
  免费   1504篇
  国内免费   1102篇
  2024年   24篇
  2023年   209篇
  2022年   258篇
  2021年   884篇
  2020年   603篇
  2019年   745篇
  2018年   832篇
  2017年   553篇
  2016年   855篇
  2015年   1165篇
  2014年   1334篇
  2013年   1484篇
  2012年   1778篇
  2011年   1566篇
  2010年   975篇
  2009年   854篇
  2008年   1074篇
  2007年   944篇
  2006年   830篇
  2005年   741篇
  2004年   591篇
  2003年   557篇
  2002年   479篇
  2001年   361篇
  2000年   298篇
  1999年   289篇
  1998年   181篇
  1997年   139篇
  1996年   100篇
  1995年   113篇
  1994年   79篇
  1993年   70篇
  1992年   96篇
  1991年   96篇
  1990年   87篇
  1989年   68篇
  1988年   56篇
  1987年   53篇
  1986年   39篇
  1985年   44篇
  1984年   23篇
  1983年   23篇
  1982年   21篇
  1981年   13篇
  1979年   20篇
  1978年   16篇
  1977年   19篇
  1976年   15篇
  1975年   14篇
  1972年   15篇
排序方式: 共有10000条查询结果,搜索用时 299 毫秒
111.
三褶脉紫菀中的新二萜甙   总被引:1,自引:0,他引:1  
三褶脉紫菀(AsterageratoidesTurcz.)系菊科多年生草本植物,遍布全国,是民间常用的中药,有清热解毒、祛痰镇咳的功效[1,2]。化学工作者们曾从其同属植物紫菀(AstertararicusL.f.)中分离到紫菀酮(shionone)、槲皮素(quercetin)、无羁萜(friedelin)、表无羁萜(epifriedelinel)、毛叶醇(lachnophyllol)、乙酸毛叶酯(lachnophyllolacetate)、茴香醚(anethole)以及紫菀三萜皂甙[2—4]…  相似文献   
112.
解离增强镧系元素荧光免疫分析灵敏度的改进   总被引:1,自引:0,他引:1  
为提高解离增强镧系荧光免疫分析(DELFIA)的灵敏度或信/噪比,进行了一些重要的方法学研究.观察到了对于不同的铕量,荧光响应和信/噪比都随着增强液体积而明显地变化.对于确定的铕量,存在一个最佳体积,且铕量越小,其最佳体积也越小.实验中选择最佳体积是重要的.研究了增强液制备技术,发展了微滴定板条有效的清洗和干燥方法,使本底荧光明显降低.  相似文献   
113.
Localization of the two Ca2+ bound to oxygen-evolving photosystemII (PSII) membranes from spinach was investigated by fractionatingthe membranes into the PSII reaction center core complexes andperipheral antenna Chl a/b-proteins after solubilization withn-heptylthioglucoside. The core complex fraction contained oneCa2+ per PSII, while another Ca2+ was found in the solubilizedmajor light-harvesting Chl a/b-proteins (LHCII). LHCII isolatedwith Triton X-100 or dodecylmaltoside also contained Ca2+ inan amount corresponding to one per PSII. The Ca2+ bound to LHCIIcould not be removed by treatment with Chelex 100, which effectivelysequestered extraneous Ca2+ bound to LHCII, or by preparationof LHCII in the presence of 40 mM citrate. Localization of thetwo Ca2+ in different functional domain of PSII membranes conclusivelyindicates that the number of the bound Ca2+ that can functionin oxygen evolution is one per PSII. The results also suggestthat one Ca2+ has a structural role in the peripheral antennaassembly. (Received July 21, 1992; Accepted March 9, 1993)  相似文献   
114.
为探讨八肽胆囊收缩素(CCk-8)和阿片肽相互作用的分子机理,利用抗体免疫沉淀技术研究了CCK-8与NDAP(k阿片受体激动剂)对大鼠脑(去皮层和小脑)和脊髓背柱组织Fos蛋白的影响。结果表明,0.1μmol/LCCK-8可显著刺激脑和脊髓组织中Fos蛋白增加(分别是对照组的3.8倍和3.6倍)。相同浓度的NDAP对Fos蛋白的生成亦有一定的诱导作用,分别是对照组的2.7倍和2.6倍。CCK-8和NDAP共同处理组织,Fos蛋白生成水平相似(脑)或高于(脊髓)CCK~-8单独诱导的水平。结果表明,CCK-8和NDAP均可直接诱导大鼠脑和脊髓组织c-fos的表达,它们对c-fos表达的相互作用在脑和脊髓中呈现不同的模式。  相似文献   
115.
The present study disclosed the cross-reactivity between Bermuda grass pollen (BGP) and other grass pollens using monoclonal antibodies (MAbs) and polyclonal antiserum. MAb 9–13, directed against a group of minor allergens of BGP (Cyn d Bd68K, 48K, 38K) was found to cross-react with extracts of ten other grass pollens. Immunoblotting assays illustrated that MAb 9–13 cross-reacted with multiple components of most of these pollens, and the major cross-reactive components had molecular weights of 29–36 kD. The cross-reactivity between BGP andLol pI, the group I allergen of rye grass pollen, was further evaluated;Lol pI was recognized by MAb 9–13, but not by our MAbs/polyclonal antiserum againstCyn dI, the major allergen of BGP. These results suggest that the epitope recognized by MAb 9–13 is a common (C) epitope shared byLol pI andCyn d Bd68K, 48K, 38K, andCyn dI does not share significant antigenicity withLol pI. In a modified radio-allergosorbent test, IgE antibodies in the serum of BGP-allergic patients reacted mildly with C-epitope-bearing components of both BGP and rye grass pollens, and this binding could be blocked specifically by MAb 9–13. This suggests that in addition to an antigenic cross-reaction, the C epitope can also lead to an allergenic cross-reaction.  相似文献   
116.
Abstract— Pretreatment with sulfhydryl-reactive agents, such as N-ethylmaleimide and p-chloromercuriphenylsul-fonic acid, invariably resulted in marked inhibition of the binding of dl -(E)-2-amino-4-[3H]propyl-5-phosphono-3-pentenoic acid ([3H]CGP 39653), a competitive antagonist at an N-methyl-d -aspartate (NMDA)-sensitive subclass of central excitatory amino acid receptors, in brain synaptic membranes extensively washed and treated with Triton X-100, but did not significantly affect the binding of L-[3H]-glutamic acid ([3H]Glu), an endogenous agonist. The pre-treatment was effective in reducing the binding of [3H]-CGP 39653 at equilibrium, without altering the initial association rate, and decreased the affinity for the ligand. Pretreatment with sulfhydryl-reactive agents also enhanced the potencies of NMDA agonists to displace [3H]-CGP 39653 binding and attenuated those of NMDA antagonists, but had little effect on the potencies of the agonists and antagonists to displace [3H]Glu binding. The binding of both [3H]CGP 39653 and [3H]Glu was similarly sensitive to pretreatment with four different proteases in Tritontreated membranes, whereas pretreatment with phospho-lipase A2 or C markedly inhibited [3H]CGP 39653 binding without altering [3H]Glu binding. Moreover, both phospho-lipases not only induced enhancement of the abilities of NMDA agonists to displace the binding of [3H]CGP 39653 and [3H]Glu, but also caused diminution of those of NMDA antagonists. These results suggest that both sulfhydryl-reactive agents and phospholipases may predominantly interfere with radiolabeling of the NMDA recognition domain in a state favorable to an antagonist by [3H]CGP 39653, with concomitant facilitation of that in an agonist-preferring form by [3H]Glu. The possible presence of multiple forms of the NMDA recognition domain is further supported by these data.  相似文献   
117.
Abstract: Pretreatment with Triton X-100 more than doubled the binding of radiolabeled 5,7-dichlorokynurenic acid (DCKA), a proposed antagonist at a glycine (Gly) recognition domain on the N-methyl-d -aspartate (NMDA) receptor ionophore complex, in rat brain synaptic membranes. The binding exhibited an inverse temperature dependency, reversibility, and saturability, the binding sites consisting of a single component with a high affinity (27.5 nM) and a relatively low density (2.87 pmol/mg of protein). The binding of both [3H]DCKA and [3H]Gly was similarly displaced by numerous putative agonists and antagonists at the Gly domain in a concentration-dependent manner at a concentration range of 100 nM to 0.1 mM. Among the 24 putative ligands tested, DCKA was the second most potent displacer of the binding of both radioligands with no intrinsic affinity for the binding of [3H]kainic acid and α-amino-3-hydroxy-5-[3H]methylisoxazole-4-propionic acid (AMPA) to the non-NMDA receptors. In contrast, the other proposed potent Gly antagonist, 5,7-dinitroquinoxaline-2,3-dione, was active in displacing the binding of [3H]glutamic ([3H]Glu) and D,L-(E)-2-amino-4-[3H]propyl-5-phosphono-3-pentenoic acids to the NMDA recognition domain with a relatively high affinity for the non-NMDA receptors. In addition, the proposed antagonist at the AMPA-sensitive receptor, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline, not only displaced weakly the binding of both [3H]- Gly and [3H]DCKA, but also inhibited the binding of (+)-5-[3H]methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine ([3H]MK-801) to an ion channel associated with the NMDA-sensitive receptor in the presence of added Glu alone in a manner sensitive to antagonism by further added Gly. Clear correlations were seen between potencies of the displacers to displace [3H]DCKA binding and [3H]Gly binding, in addition to between the potencies to displace [3H]-DCKA or [3H]Gly binding and to potentiate or inhibit [3H]MK-801 binding. All quinoxalines tested were invariably more potent displacers of [3H]DCKA binding than [3H]Gly binding, whereas kynurenines were similarly effective in displacing the binding of both [3H]Gly and [3H]-DCKA. These results undoubtedly give support to the proposal that [3H]DCKA is one useful radioligand available in terms of its high selectivity and affinity for the Gly domain in the brain. Possible multiplicity of the Gly domain is suggested by the differential pharmacological profiles between the binding of [3H]Gly and [3H]DCKA.  相似文献   
118.
Calymenesun granulosa Lu的背壳及接合构造*   总被引:1,自引:0,他引:1  
韩乃仁 《古生物学报》1993,32(5):587-595
描述了Calymenesun granulosa Lu的腹边缘及结合构造,并讨论了此种三叶虫的卷曲机制。认为当其卷曲完善时,尾“边缘“及部分胸肋纳入头颊下,以往描述了尾边缘的部分实际上是尾背结合沟所在位置。卷曲形式为半螺旋卷曲。  相似文献   
119.
120.
Y W Han  R I Gumport    J F Gardner 《The EMBO journal》1993,12(12):4577-4584
Site-specific recombination of bacteriophage lambda starts with the formation of higher-order protein--DNA complexes, called 'intasomes', and is followed by a series of steps, including the initial DNA cleavage, top-strand exchange, branch migration and bottom-strand exchange, to produce recombinant products. One of the intasomes formed during excisive recombination (the attL complex) is composed of the phage-encoded integrase (Int), integration host factor (IHF) and one of the recombination substrates, attL DNA. Int is the catalytic recombinase and has two different DNA binding domains. When IHF is present, Int binds to two types of sites in attL DNA, the three arm-type sites (P'123) and the core-type sites (B and C') where the reciprocal strand exchange takes place. The Tyr342 residue of Int serves as a nucleophile during strand cleavage and covalently attaches to the DNA through a phosphotyrosyl bond. In vitro complementation assays have been performed for strand cleavage using attL suicide substrates and mutant proteins containing amino acid substitutions at residues conserved in the integrase family of recombinases. We demonstrate that at least two Int monomers are required to form the catalytically-competent species that performs cleavage at the B site. It is likely that the active site is formed by two Int monomers.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号